The therapeutic potential of novel cannabinoid receptors
- 1 May 2009
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 122 (2) , 83-96
- https://doi.org/10.1016/j.pharmthera.2009.01.005
Abstract
No abstract availableKeywords
This publication has 187 references indexed in Scilit:
- Sphingosine-1-phosphate receptors: Biology and therapeutic potential in kidney diseaseKidney International, 2008
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- Novel cannabinoid receptorsBritish Journal of Pharmacology, 2007
- Cannabinoid activation of PPARα; a novel neuroprotective mechanismBritish Journal of Pharmacology, 2007
- Vascular pharmacology of a novel cannabinoid‐like compound, 3‐(5‐dimethylcarbamoyl‐pent‐1‐enyl)‐N‐(2‐hydroxy‐1‐methyl‐ethyl)benzamide (VSN16) in the ratBritish Journal of Pharmacology, 2007
- Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptorsBritish Journal of Pharmacology, 2007
- The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effectsBritish Journal of Pharmacology, 2007
- Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aortaBritish Journal of Pharmacology, 2007
- Interaction of ligands for the peroxisome proliferator‐activated receptor γ with the endocannabinoid systemBritish Journal of Pharmacology, 2007
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitroBritish Journal of Pharmacology, 2007